Factors | Â | Overall Survival (OS) | Disease-free Survival (DFS) | ||||
---|---|---|---|---|---|---|---|
Univariate | Multivare | Univariate | Multivariate | ||||
P | HR (95% CI) | P | P | HR (95% CI) | P | ||
Characteristic of | Age: >50 vs. ≤50 years* | 0.719 |  | NA | 0.981 |  | NA |
Demography, | Gender: male vs. female | 0.846 | Â | NA | 0.088 | Â | NA |
Tumor & | Tumor size: >5 vs. ≤5 cm | 0.061 |  | NA | 0.130 |  | NA |
Laboratory | Tumor number: multiple vs. single | 0.221 | Â | NA | 0.192 | Â | NA |
Tests | Serum AFP: ≥400 vs. <400 ng/ml | 0.285 |  | NA | 0.382 |  | NA |
 | Serum CA199 ≥ 37 vs. < 37 U/ml | 0.798 |  | NA | 0.236 |  | NA |
 | TNM stage: I/II vs. III | 0.030* |  | NS | 0.001* | 1.817 (1.135-2.909) | 0.013* |
 | Edmondson grade: I/II vs. III/IV | 0.074 |  | NA | 0.043* |  | NS |
 | Macrovascular Invasion: P vs. N | 0.014* |  | NS | 0.114 |  | NA |
 | Tumor encapsulation: absence vs. presence | 0.791 |  | NA | 0.311 |  | NA |
Histology: | Ishak grade >7 vs. ≤ 7 | 0.058 |  | NA | 0.072 |  | NA |
Peritumor | Ishak stage >5 vs. ≤ 5 | 0.096 |  | NA | 0.120 |  | NA |
 | PI-DR ≥ 50% vs. <50% | <0.001* | 3.316(1.961-5.610) | <0.001* | <0.001* | 2.618(1.701-4.029) | <0.001* |
 | K7-DR ≥ 50% vs. <50% | 0.045* | 1.863(1.008-3.443) | 0.047* | 0.158 |  | NA |
 | EpCAMPeritumor Expression H vs. L* | 0.319 |  | NA | 0.003* |  | NS |
 | OV6Peritumor Expression H vs. L* | 0.191 |  | NA | 0.702 |  | NA |
 | C-kitPeritumorExpression H vs. L* | 0.721 |  | NA | 0.935 |  | NA |
 | CD133Peritumor Expression H vs. L* | 0.051 |  | NA | <0.001* |  | NS |
Histology: | Microvascular invasion: P vs. N | 0.327 | Â | NA | 0.595 | Â | NA |
Tumor: | EpCAM Expression H vs. L* | 0.017* | Â | NS | 0.093 | Â | NA |
 | OV6 Expression H vs. L* | 0.756 |  | NA | 0.034* |  | NS |
 | C-kit Expression H vs. L* | 0.352 |  | NA | 0.127 |  | NA |
 | CD133 Expression H vs. L* | 0.394 |  | NA | 0.091 |  | NA |